Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.52NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.11.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.48NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JQ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.10.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
BA.5.2.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.9.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.6.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.9.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.4.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.71NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DN.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CL.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.3.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DB.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CZ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FK.1.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.26.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DS.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FS.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.54NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.15 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.348NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.575NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.4 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.442NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used